Trademark: 97243599
Word
MABLYTICS
Status Date
Monday, March 25, 2024
Filing Date
Friday, January 28, 2022
Published for Opposition
Tuesday, December 27, 2022
Abandoned Date
Monday, March 25, 2024
5 Pharmaceutical preparations and substances for the treatment of oncological diseases and disorders; Pharmaceutical preparations and substances for the treatment of immune system diseases and disorders; all of the foregoing containing monoclonal antibodies
The mark consists of a chevron design which is pointing at the word "MABLYTICS".
Color is not claimed as a feature of the mark.
Mar 25, 2024
Abandonment Notice E-Mailed - No Use Statement Filed
Mar 25, 2024
Abandonment - No Use Statement Filed
Aug 16, 2023
Teas Change Of Correspondence Received
Aug 16, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Aug 16, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Aug 9, 2023
Notice Of Approval Of Extension Request E-Mailed
Aug 7, 2023
Sou Extension 1 Granted
Aug 7, 2023
Sou Extension 1 Filed
Aug 7, 2023
Sou Teas Extension Received
Feb 21, 2023
Noa E-Mailed - Sou Required From Applicant
Dec 27, 2022
Official Gazette Publication Confirmation E-Mailed
Dec 27, 2022
Published For Opposition
Dec 7, 2022
Notification Of Notice Of Publication E-Mailed
Nov 21, 2022
Approved For Pub - Principal Register
Nov 16, 2022
Examiner's Amendment Entered
Nov 16, 2022
Notification Of Examiners Amendment E-Mailed
Nov 16, 2022
Examiners Amendment E-Mailed
Nov 16, 2022
Examiners Amendment -Written
Nov 9, 2022
Assigned To Examiner
Aug 5, 2022
Teas Change Of Correspondence Received
Aug 5, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Aug 5, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jun 30, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Jun 30, 2022
Teas Change Of Correspondence Received
Jun 30, 2022
Teas Change Of Owner Address Received
Feb 2, 2022
Notice Of Design Search Code E-Mailed
Feb 1, 2022
New Application Office Supplied Data Entered
Feb 1, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24